Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (121-130 of 333) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Clinical toxicity of interferons in cancer patients: a reviewJ R Quesada, M Talpaz, A Rios, et al.
Journal of Internal Medicine|October 1, 1993
Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinomaM Wetzler, Z Estrov, M Talpaz, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1993
A phase-I clinical study of low-dose oral interferon-alphaK Dhingra, M Duvic, S Hymes, et al.
Leukemia|November 1, 1991
Erythropoietin treatment in patients with myelodysplastic syndrome and anemiaR Kurzrock, M Talpaz, E Estey, et al.
Nature|October 28, 1976
Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patientsP Minden, C Jarrett, J K McClatchy, et al.
Behring Institute Mitteilungen|August 1, 1988
Phase I study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with bone marrow failure and malignancyS Vadhan-Raj, M J Kellagher, M Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1988
A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patientsB Feinberg, R Kurzrock, M Talpaz, et al.
Blood|May 1, 1987
Expression of c-fos, c-myb, and c-myc in human monocytes: correlation with monocytic differentiationJ Lee, K Mehta, M B Blick, et al.
FEBS Letters|November 20, 1998
p202 self-associates through a sequence conserved among the members of the 200-family proteinsD Koul, N U Obeyesekere, J U Gutterman, et al.
Cancer|December 1, 1979
Nodular malignant lymphomas: factors affecting complete response rate and survivalF Cabanillas, T Smith, G P Bodey, et al.
Pageof 34

Showing results (121-130 of 333) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Clinical toxicity of interferons in cancer patients: a reviewJ R Quesada, M Talpaz, A Rios, et al.
Journal of Internal Medicine|October 1, 1993
Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinomaM Wetzler, Z Estrov, M Talpaz, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1993
A phase-I clinical study of low-dose oral interferon-alphaK Dhingra, M Duvic, S Hymes, et al.
Leukemia|November 1, 1991
Erythropoietin treatment in patients with myelodysplastic syndrome and anemiaR Kurzrock, M Talpaz, E Estey, et al.
Nature|October 28, 1976
Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patientsP Minden, C Jarrett, J K McClatchy, et al.
Behring Institute Mitteilungen|August 1, 1988
Phase I study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with bone marrow failure and malignancyS Vadhan-Raj, M J Kellagher, M Keating, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1988
A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patientsB Feinberg, R Kurzrock, M Talpaz, et al.
Blood|May 1, 1987
Expression of c-fos, c-myb, and c-myc in human monocytes: correlation with monocytic differentiationJ Lee, K Mehta, M B Blick, et al.
FEBS Letters|November 20, 1998
p202 self-associates through a sequence conserved among the members of the 200-family proteinsD Koul, N U Obeyesekere, J U Gutterman, et al.
Cancer|December 1, 1979
Nodular malignant lymphomas: factors affecting complete response rate and survivalF Cabanillas, T Smith, G P Bodey, et al.
Pageof 34